dEEGtal Insight SA is a pioneering spin-off of Geneva University Hospitals (the EEG and Epilepsy Unit) and the University of Geneva that develops AI-powered software to improve early detection and diagnosis of epilepsy. Its technology automates EEG analysis, offering automated medical reporting, automatic slowing detection, and a comprehensive overview of EEG signals to simplify clinicians' workflows. The product aims to increase detection accuracy and guide neurologists toward informed decisions, enabling earlier intervention and better patient outcomes. The company is positioning its tool for clinical and market impact through partnerships with academic and medical institutions. Financially, the Wyss Center has invested CHF 750,000 to support dEEGtal Insight's next stage of growth and development. Clinicians, researchers, and health-tech professionals are directed to the company website for more information.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2024